[1] |
Beck LH, Jr.Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy [J]. N Engl J Med, 2009, 361(1): 11-21.
|
[2] |
Geneva: World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection [EB/OL]. 2015:
URL
|
[3] |
Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents [J]. MMWR Recomm Rep, 2005, 54(RR-16): 1-31.
|
[4] |
Yang Y, Zhang Z, Zhuo L, et al. The spectrum of biopsy-proven glomerular disease in China: a systematic review [J]. Chin Med J (Engl), 2018, 131(6): 731-735.
|
[5] |
Pourcine F, Dahan K, Mihout F, et al. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: a single-centre study over 14 years [J]. PLoS One, 2017, 12(3): e0173201.
|
[6] |
Xie Q, Li Y, Xue J, et al. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy [J]. Am J Nephrol, 2015, 41(4-5): 345-353.
|
[7] |
Lin L, Wang WM, Pan XX, et al. Biomarkers to detect membranous nephropathy in Chinese patients [J]. Oncotarget, 2016, 7(42): 67868-67879.
|
[8] |
Wang J, Cui Z, Lu J, et al. Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy [J]. Clin J Am Soc Nephrol, 2017, 12(10): 1642-1651.
|
[9] |
Hofstra JM, Beck LH, Jr. Beck DM, et al. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy [J]. Clin J Am Soc Nephrol, 2011, 6(6): 1286-1291.
|
[10] |
Hoxha E, Thiele I, Zahner G, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy [J]. J Am Soc Nephrol, 2014, 25(6): 1357-1366.
|